MedDataX Logo

Structured Light Plethysmography Against Standard of Care in the Diagnosis and Monitoring of Dysfunctional Breathing

NCT04255446 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-04-03

No results posted yet for this study

Summary

This is an observational, controlled, single-centre study to validate the Thora3Di™ against standard practice in patients who are undergoing investigation for disproportionate breathlessness. The core methodology involves capturing of data during a short period of measurement of breathing using SLP.

Conditions

  • Dysfunctional Breathing

Interventions

DEVICE

Thora3DiTM

Not international

Sponsors & Collaborators

  • Pneumacare Ltd

    lead INDUSTRY

Principal Investigators

  • Aashish Vyas, MD · Royal Preston Hospital

Eligibility

Min Age
16 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-31
Primary Completion
2026-08-31
Completion
2026-10-31

Countries

  • United Kingdom

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04255446 on ClinicalTrials.gov